PCK1 and hepatocellular carcinoma: In HCC, the expression of PCK1 is downregulated, leading to the accumulation of OAA, increased de novo synthesis of UTP, and activation of the hexosamine biosynthesis pathway (HBP), which contributes to the biosynthesis of uridine diphosphate N-acetylglucosamine (UDP-GlcNAc).